Cargando…
Widening spectrum of neuroleptic malignant syndrome: Case series
Neuroleptic malignant syndrome (NMS) is a rare and rapidly progressive syndrome with mortality rate of 5.6%. The spectrum of onset, progression and outcome is heterogeneous and is associated with number of risk factors. In our case series, we entail the triggers, hospital course and outcome of five...
Autores principales: | Paul, Gunchan, Singhal, Sachi, Paul, Birinder S., Singh, Gurparvesh, Goyal, Shriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511852/ https://www.ncbi.nlm.nih.gov/pubmed/36171930 http://dx.doi.org/10.4103/joacp.JOACP_8_21 |
Ejemplares similares
-
Aggressive Vertebral Hemangioma: The Mystery of Spastic Legs Unveiled by a Purple Shoulder
por: Goraya, Gurparvesh S, et al.
Publicado: (2022) -
Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma
por: Paul, Gunchan, et al.
Publicado: (2016) -
Unabridged Histoplasmosis Myositis: Unsolved Dissemination with Diagnostic Challenge
por: Goraya, Gurparvesh S., et al.
Publicado: (2021) -
Factors Affecting Adherence to Pharmacotherapy in Parkinson's Disease
por: Aggarwal, Shivaansh, et al.
Publicado: (2021) -
Assessment of knowledge gaps and perceptions about COVID-19 among health care workers and general public-national cross-sectional study
por: Paul, Gunchan, et al.
Publicado: (2020)